Comparison of Postoperative Recovery Quality in Elderly Patients with Fragile Brain Function under the Guidance of BIS between Remimazolam and Propofol

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500095177

Enrollment

Unknown

Registered

2025-01-02

Start date

2025-01-15

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitive dysfunction

Interventions

Remimazolam Group (Experimental Group):None

Propofol Group (Control Group):None

Eligibility

Sex/Gender

All

Age

65 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1 Elective surgery patients with fragile brain function; 2 Age: 65 to 75 years; 3 BMI: 18 to 28 kg/m²; 4 ASA: Class I to III; 5 Estimated surgery duration: 2 to 6 hours;

Exclusion criteria

Exclusion criteria: 1 Patients with significant dysfunction of the heart, lungs, liver, or kidneys; 2 Patients with neurological or psychiatric disorders; 3 Patients with a history of allergy to benzodiazepines or propofol; 4 Patients with a history of abuse of opioid analgesics and alcohol; 5 Patients with skin damage or infection in the BIS monitoring area.

Design outcomes

Primary

Measure	Time frame
Quality of Recovery,QoR;	—

Countries

China

Contacts

Public ContactDai Junchao

Affiliated Hospital of Southwest Medical University

563957438@qq.com+86 159 0826 9859

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026